186 related articles for article (PubMed ID: 28504713)
1. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.
Read ML; Fong JC; Modasia B; Fletcher A; Imruetaicharoenchoke W; Thompson RJ; Nieto H; Reynolds JJ; Bacon A; Mallick U; Hackshaw A; Watkinson JC; Boelaert K; Turnell AS; Smith VE; McCabe CJ
Oncogene; 2017 Sep; 36(37):5296-5308. PubMed ID: 28504713
[TBL] [Abstract][Full Text] [Related]
2. PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer.
Read ML; Modasia B; Fletcher A; Thompson RJ; Brookes K; Rae PC; Nieto HR; Poole VL; Roberts S; Campbell MJ; Boelaert K; Turnell AS; Smith VE; Mehanna H; McCabe CJ
Cancer Res; 2018 Oct; 78(20):5863-5876. PubMed ID: 30154144
[TBL] [Abstract][Full Text] [Related]
3. PTTG and PBF repress the human sodium iodide symporter.
Boelaert K; Smith VE; Stratford AL; Kogai T; Tannahill LA; Watkinson JC; Eggo MC; Franklyn JA; McCabe CJ
Oncogene; 2007 Jun; 26(30):4344-56. PubMed ID: 17297475
[TBL] [Abstract][Full Text] [Related]
4. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.
Read ML; Lewy GD; Fong JC; Sharma N; Seed RI; Smith VE; Gentilin E; Warfield A; Eggo MC; Knauf JA; Leadbeater WE; Watkinson JC; Franklyn JA; Boelaert K; McCabe CJ
Cancer Res; 2011 Oct; 71(19):6153-64. PubMed ID: 21844185
[TBL] [Abstract][Full Text] [Related]
5. The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.
Read ML; Seed RI; Fong JC; Modasia B; Ryan GA; Watkins RJ; Gagliano T; Smith VE; Stratford AL; Kwan PK; Sharma N; Dixon OM; Watkinson JC; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
Endocrinology; 2014 Apr; 155(4):1222-34. PubMed ID: 24506068
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake.
Smith VE; Franklyn JA; McCabe CJ
J Endocrinol; 2011 Aug; 210(2):157-63. PubMed ID: 21450804
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
[TBL] [Abstract][Full Text] [Related]
8. The pituitary tumor transforming gene in thyroid cancer.
Lewy GD; Sharma N; Seed RI; Smith VE; Boelaert K; McCabe CJ
J Endocrinol Invest; 2012 Apr; 35(4):425-33. PubMed ID: 22522436
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.
Smith VE; Read ML; Turnell AS; Watkins RJ; Watkinson JC; Lewy GD; Fong JC; James SR; Eggo MC; Boelaert K; Franklyn JA; McCabe CJ
J Cell Sci; 2009 Sep; 122(Pt 18):3393-402. PubMed ID: 19706688
[TBL] [Abstract][Full Text] [Related]
10. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.
Read ML; Seed RI; Modasia B; Kwan PP; Sharma N; Smith VE; Watkins RJ; Bansal S; Gagliano T; Stratford AL; Ismail T; Wakelam MJ; Kim DS; Ward ST; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
Mol Carcinog; 2016 Jan; 55(1):15-26. PubMed ID: 25408419
[TBL] [Abstract][Full Text] [Related]
11. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product.
Chien W; Pei L
J Biol Chem; 2000 Jun; 275(25):19422-7. PubMed ID: 10781616
[TBL] [Abstract][Full Text] [Related]
12. Regulation of pituitary tumor transforming gene (PTTG) expression and phosphorylation in thyroid cells.
Lewy GD; Ryan GA; Read ML; Fong JC; Poole V; Seed RI; Sharma N; Smith VE; Kwan PP; Stewart SL; Bacon A; Warfield A; Franklyn JA; McCabe CJ; Boelaert K
Endocrinology; 2013 Nov; 154(11):4408-22. PubMed ID: 23867215
[TBL] [Abstract][Full Text] [Related]
13. PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.
Smith VE; Read ML; Turnell AS; Sharma N; Lewy GD; Fong JC; Seed RI; Kwan P; Ryan G; Mehanna H; Chan SY; Darras VM; Boelaert K; Franklyn JA; McCabe CJ
Endocrinology; 2012 Jul; 153(7):3526-36. PubMed ID: 22535767
[TBL] [Abstract][Full Text] [Related]
14. Pituitary tumor-transforming gene and its binding factor in endocrine cancer.
Smith VE; Franklyn JA; McCabe CJ
Expert Rev Mol Med; 2010 Dec; 12():e38. PubMed ID: 21129230
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells.
Kim D; Pemberton H; Stratford AL; Buelaert K; Watkinson JC; Lopes V; Franklyn JA; McCabe CJ
Oncogene; 2005 Jul; 24(30):4861-6. PubMed ID: 15897900
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer.
Kim DS; Franklyn JA; Stratford AL; Boelaert K; Watkinson JC; Eggo MC; McCabe CJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1119-28. PubMed ID: 16394085
[TBL] [Abstract][Full Text] [Related]
17. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.
Smith VE; Sharma N; Watkins RJ; Read ML; Ryan GA; Kwan PP; Martin A; Watkinson JC; Boelaert K; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2013 Jul; 98(7):2876-86. PubMed ID: 23678037
[TBL] [Abstract][Full Text] [Related]
19. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
20. Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.
Watkins RJ; Imruetaicharoenchoke W; Read ML; Sharma N; Poole VL; Gentilin E; Bansal S; Bosseboeuf E; Fletcher R; Nieto HR; Mallick U; Hackshaw A; Mehanna H; Boelaert K; Smith VE; McCabe CJ
J Clin Endocrinol Metab; 2016 Dec; 101(12):4551-4563. PubMed ID: 27603901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
